2142562-01-2

5-Fluoro-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl Acetate, is an impurity of Crisaborole, a nonsteroidal topical medication approved for the treatment of mild-to-moderate atopic dermatitis in patients 2 years of age and older.